SEARCH RESULT

Total Matching Records found : 5631

A question of proportion

-The Hindu If a citizen applies to the government for security cover, is the latter bound to oblige him even if he is the country's most wealthy individual? The short answer is yes, provided the government finds the threat credible. Why then has the decision to accord Mukesh Ambani ‘Z' category security - which is second only to the ‘Z-plus' protection accorded to such VVIPs as the Prime Minister, the President,...

More »

Supreme Court and the aam aadmi -G Mohan Gopal

-Frontline It is the goal of social revolution that connects the aam aadmi to the judiciary and to its highest institution, the Supreme Court of India. By Prof. G. MOHAN GOPAL WHAT should be the appropriate mea-sure of the relationship between the apex court of a country and its common people? Should an apex court be evaluated by who invokes its jurisdiction, from which area and for what purpose? Is an apex...

More »

Jairam dancing to the tune of corporate lobby: Brinda Karat

-The Hindu Left parties to press for referring land acquisition bill to panel VISAKHAPATNAM: Continuing her tirade against attempts by the UPA Government to adopt the Land Acquisition, Rehabilitation and Resettlement Bill, 2011, in Parliament without addressing the concerns expressed by many, CPI (M) Polit Bureau member Brinda Karat on Sunday accused Union Minister for Rural Development Jairam Ramesh of dancing to the tune of the corporate lobby. At a seminar on ‘Tribal...

More »

Rajasthan govt to give free cancer drugs -Syed Intishab Ali

-The Times of India JAIPUR: In a major relief for blood cancer patients, the state's health department is all set to provide Imatinib tablets ("magic bullet" tablets) free of cost to them. The government's decision follows the April 1 Supreme Court decision to dismiss Swiss drug maker Novartis AG's attempt to win patent protection for its cancer drug Glivec (Imatinib). Currently the tablet is sold in the market by Novartis at...

More »

Landmark verdict -V Venkatesan

-Frontline   The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close